Cable Hill Partners, LLC Invitae Corp Transaction History

Cable Hill Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$17.37 - $26.27 $34,740 - $52,540	-2,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$9.26 - $16.38 $17,594 - $31,121	1,900 Added 1900.0%	2,000 $22,000
Q3 2018 Nov 14, 2018	SELL	$7.54 - $18.31 $14,326 - $34,789	-1,900 Reduced 95.0%	100 $1,000
Q2 2018 Aug 03, 2018	BUY	$4.87 - $8.42 $9,740 - $16,840	2,000 New	2,000 $15,000
Q1 2018 Apr 20, 2018	SELL	$4.69 - $10.05 $4,690 - $10,050	-1,000 Closed	0 $0
Q4 2017 Feb 22, 2018	SELL	$7.86 - $9.99 $7,860 - $9,990	-1,000 Reduced 50.0%	1,000 $10,000
Q3 2017 Oct 27, 2017	BUY	$8.89 - $10.4 $17,780 - $20,800	2,000	2,000 $19,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.